The US Food and Drug Administration (FDA) on Wednesday published draft guidance on the US Pharmacopoeial Convention Pending Monograph Process (USP-PMP), outlining how sponsors can revise or create new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results